×

Glucose-dependent insulinotropic peptide for use as an osteotropic hormone

  • US 6,410,508 B1
  • Filed: 10/07/1999
  • Issued: 06/25/2002
  • Est. Priority Date: 10/07/1998
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for maintaining or increasing bone density or formation in a female subject having reduced bone mineralization associated with reduced ovarian function comprising administration of an effective amount of Glucose-Dependent Insulinotropic Peptide (GIP) as a pharmaceutically acceptable formulation to said subject, wherein said effective amount comprises sufficient GIP polypeptide to maintain or increase bone density in said subject.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×